Shalata, W., et al.. Adjuvant Treatment with Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor Mutated Non-small-cell Lung Carcinoma Patients, Past, Present and Future. no. 16, MDPI AG, Aug. 2021, doi:10.3390/cancers13164119.